Christine Marie Utter

Companies

• PTC TherapeuticsPrincipal Financial Officer Jun 6, 2017 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PTC Therapeutics PTCT70,199 shares²$4.3M at $61.38Jun 17, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 17, 2026Sold 19,686 shares at $75.56 of PTC Therapeutics²
• Jun 17, 2026Exercised options 19,686 shares at $25.69 of PTC Therapeutics²
• Feb 18, 2026Sold 2,494 shares at $69.36 of PTC Therapeutics³
• Jan 8, 2026Sold 1,034 shares at $76.45 of PTC Therapeutics⁴
• Jan 7, 2026Sold 1,235 shares at $77.45 of PTC Therapeutics⁵
• Jan 6, 2026Sold 1,381 shares at $76.95 of PTC Therapeutics⁵
• Jan 2, 2026Granted 13,250 shares of PTC Therapeutics⁶
• Feb 20, 2025Sold 878 shares at $50.12 of PTC Therapeutics⁷
• Feb 19, 2025Sold 879 shares at $50.10 of PTC Therapeutics⁷
• Jan 8, 2025Sold 1,662 shares at $44.50 of PTC Therapeutics⁸
• Jan 7, 2025Sold 1,291 shares at $45.34 of PTC Therapeutics⁸
• Jan 3, 2025Granted 14,000 shares of PTC Therapeutics⁹
• Dec 2, 2024Sold 4,776 shares at $52.45 of PTC Therapeutics¹⁰
• Dec 2, 2024Sold 9,919 shares at $51.53 of PTC Therapeutics¹⁰
• Dec 2, 2024Exercised options 14,695 shares at $51.00 of PTC Therapeutics¹⁰
• Dec 2, 2024Sold 608 shares at $52.24 of PTC Therapeutics¹⁰
• Dec 2, 2024Sold 2,497 shares at $51.34 of PTC Therapeutics¹⁰
• Dec 2, 2024Exercised options 3,105 shares at $51.00 of PTC Therapeutics¹⁰
• Feb 15, 2024Granted 2,900 shares of PTC Therapeutics¹¹
• Feb 15, 2024Granted 14,000 shares of PTC Therapeutics¹¹
• Jan 30, 2024Sold 318 shares at $27.25 of PTC Therapeutics¹²
• Jan 9, 2024Sold 1,653 shares at $29.01 of PTC Therapeutics¹³
• Jan 8, 2024Sold 1,188 shares at $28.64 of PTC Therapeutics¹³
• Apr 21, 2023Sold 20 shares at $55.64 of PTC Therapeutics¹⁴
• Apr 21, 2023Sold 351 shares at $55.09 of PTC Therapeutics¹⁴